bioRxivEvolutionary Biology
Pleiotropy promotes the evolution of inducible immune responses in a model of host-pathogen coevolution
Abstract
Components of immune systems face significant selective pressure to efficiently use organismal resources, mitigate infection, and resist parasitic manipulation. A theoretically optimal immune defense balances investment in constitutive and inducible immune components depending on the kinds of parasites encountered, but genetic and dynamic constraints can force deviation away from theoretical optima. One such potential constraint is pleiotropy, the phenomenon where a single gene affects multiple phenotypes. Although pleiotropy can prevent or dramatically slow adaptive evolution, it is prevalent in the signaling networks that compose metazoan immune systems. We hypothesized that pleiotropy is maintained in immune signaling networks despite slowed adaptive evolution because it provides some other advantage, such as forcing network evolution to compensate in ways that increase host fitness during infection. To study the effects of pleiotropy on the evolution of immune signaling networks, we used an agent-based modeling approach to evolve a population of host immune systems infected by simultaneously co-evolving parasites. Four kinds of pleiotropic restrictions on evolvability were incorporated into the networks, and their evolutionary outcomes were compared to, and competed against, non-pleiotropic networks. As the networks evolved, we tracked several metrics of immune network complexity, relative investment in inducible and constitutive defenses, and features associated with the winners and losers of competitive simulations. Our results suggest non-pleiotropic networks evolve to deploy highly constitutive immune responses regardless of parasite prevalence, but some implementations of pleiotropy favor the evolution of highly inducible immunity. These inducible pleiotropic networks are no less fit than non-pleiotropic networks and can out-compete non-pleiotropic networks in competitive simulations. These provide a theoretical explanation for the prevalence of pleiotropic genes in immune systems and highlight a mechanism that could facilitate the evolution of inducible immune responses. Author SummaryGenes involved in immune defense are hotspots of adaptive evolution as they resist rapidly evolving parasites and pathogens. Pleiotropic genes, which affect multiple discrete traits, have been shown to evolve at a much slower rate than non-pleiotropic genes but are highly represented in the immune system. The evolutionary effects of pleiotropic signaling genes on immune evolution are poorly understood, so we developed a model of pleiotropic signaling network evolution to address this gap in knowledge. Our results show that pleiotropy may be an important genomic feature in the development of inducible immunity.
- research focus: host-pathogen & immune response
- research focus: benchmarking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pleiotropy alleviates the fitness costs associated with resource allocation trade-offs in immune signaling networks
R. Martin, A. T. Tate·bioRxiv·Oct 6, 2023
- The effect of developmental pleiotropy on the evolution of insect immune genes
T. M. Ngo, A. M. Williams, A. T. Tate·bioRxiv·May 12, 2021
- Pleiotropy constrains the evolution of immune system plasticity while promoting domain modularity
Danial Asgari, Ann Thomas Tate·bioRxiv·May 29, 2026
- Beneficial microbes may have favoured the evolution of adaptive immunity
Lucas Mathieu, Thomas Pradeu, … Kevin N. Laland·bioRxiv·Mar 25, 2026
- The role of uncertainty and negative feedback loops in the evolution of induced immune defenses
D. Asgari, A. J. Stewart, R. P. Meisel·bioRxiv·Oct 11, 2022
- Natural variation in the contribution of microbial density to inducible immune dynamics
D. G. Jent, A. Perry, … A. T. Tate·bioRxiv·Oct 1, 2019